Persistence of Pseudomonas aeruginosa strains in respiratory infection in AIDS patients

被引:25
作者
Asboe, D
Gant, V
Aucken, HM
Moore, DA
Umasankar, S
Bingham, JS
Kaufmann, ME
Pitt, TL
机构
[1] St Thomas Hosp, Dept Genitourinary HIV Med, London, England
[2] United Med & Dent Sch Guys & St Thomas, Div Infect & Immun, London SE1 7EH, England
[3] Cent Publ Hlth Lab, Lab Hosp Infect, London NW9 5HT, England
[4] Chelsea & Westminster Hosp, Dept Genitourinary HIV Med, London, England
[5] Chelsea & Westminster Hosp, Dept Microbiol, London, England
关键词
Pseudomonas aeruginosa; bacterial infection; HIV; severe immunosuppression; respiratory tract infection; cystic fibrosis;
D O I
10.1097/00002030-199814000-00008
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objectives: To establish the clinical pattern of Pseudomonas aeruginosa respiratory infections in HIV-seropositive patients and to determine whether repeated isolation of the organism represents reinfection or recurrence and to assess whether common source, nosocomial infection occurred. Design and methods: Evaluation of the clinical pattern of P. aeruginosa respiratory infections by case note review and epidemioiogical characterization of P. aeruginosa by serotype determination and Xbal DNA macrorestriction analysis. Serum sensitivity testing of strains was performed to further define phenotypic characteristics of the isolated organisms. Results: Seventy-three per cent (29 out of 40) of individuals had P. aeruginosa isolated on two or more occasions in the setting of clinical respiratory infection. Overall, 85% had evidence of P. aeruginosa to within 2 months of study completion or death. Epidemiological characterization revealed persistence of unique single strains in 93% of individuals where multiple isolates were available for testing, whereas only two patients harboured a common strain. The serotype distribution of strains was similar to that reported from non-HIV-positive patients. Conclusions: Once established, eradication of P. aeruginosa from the respiratory tract of HIV-seropositive individuals with advanced immunosuppression is problematic and a chronic infective state appears common. There was no evidence of nosocomial transmission. Serotype loss and development of sensitivity to normal human serum were both observed and were highly correlated. This represents truncation of Q-antigenic lipopolysaccharide on the cell surface of P. aeruginosa and may reflect progression to phenotypes commonly associated with chronic infection in other clinical settings such as cystic fibrosis. (C) 1998 Lippincott Williams & Wilkins.
引用
收藏
页码:1771 / 1775
页数:5
相关论文
共 19 条
[1]  
ALI NJ, 1995, GENITOURIN MED, V71, P73
[2]   PSEUDOMONAS-AERUGINOSA BRONCHOPULMONARY INFECTION IN LATE HUMAN-IMMUNODEFICIENCY-VIRUS DISEASE [J].
BARON, AD ;
HOLLANDER, H .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 148 (04) :992-996
[3]   ROLE OF LIPOPOLYSACCHARIDE IN VIRULENCE OF PSEUDOMONAS-AERUGINOSA [J].
CRYZ, SJ ;
PITT, TL ;
FURER, E ;
GERMANIER, R .
INFECTION AND IMMUNITY, 1984, 44 (02) :508-513
[4]   Cystic fibrosis [J].
Davis, PB ;
Drumm, M ;
Konstan, MW .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 154 (05) :1229-1256
[5]   CLINICAL MANIFESTATIONS AND RISK-FACTORS OF PSEUDOMONAS-AERUGINOSA INFECTION IN PATIENTS WITH AIDS [J].
DROPULIC, LK ;
LESLIE, JM ;
ELDRED, LJ ;
ZENILMAN, J ;
SEARS, CL .
JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (04) :930-937
[6]   DISCRIMINATORY POWER OF 3 DNA-BASED TYPING TECHNIQUES FOR PSEUDOMONAS-AERUGINOSA [J].
GRUNDMANN, H ;
SCHNEIDER, C ;
HARTUNG, D ;
DASCHNER, FD ;
PITT, TL .
JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (03) :528-534
[7]   PSEUDOMONAS-AERUGINOSA ISOLATES FROM PATIENTS WITH CYSTIC-FIBROSIS - A CLASS OF SERUM-SENSITIVE, NONTYPABLE STRAINS DEFICIENT IN LIPOPOLYSACCHARIDE-O SIDE-CHAINS [J].
HANCOCK, REW ;
MUTHARIA, LM ;
CHAN, L ;
DARVEAU, RP ;
SPEERT, DP ;
PIER, GB .
INFECTION AND IMMUNITY, 1983, 42 (01) :170-177
[8]   ESTIMATED RISK OF CROSS-INFECTION WITH PSEUDOMONAS-AERUGINOSA IN DANISH CYSTIC-FIBROSIS PATIENTS [J].
HOIBY, N ;
PEDERSEN, SS .
ACTA PAEDIATRICA SCANDINAVICA, 1989, 78 (03) :395-404
[9]  
HOIBY N, 1975, ACTA PATH MICRO IM B, V83, P549
[10]  
Kaufmann ME., 1994, METHODS PRACTICAL LA, P83